Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2018 to Q4 2025

Type / Class
Equity / Common stock, par value $0.01 per share
Symbol
MBOT on Nasdaq
Shares outstanding
52,664,292
Price per share
$2.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,848,942
Total reported value
$30,049,535
% of total 13F portfolios
0%
Share change
+5,462,033
Value change
+$16,709,543
Number of holders
66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.4% -20% $7,147,861 +$893,415 2,343,561 +14% The Vanguard Group 30 Sep 2025
CVI Investments, Inc. 4.9% -20% $4,780,994 +$1,487,280 1,824,807 +45% CVI Investments, Inc. 31 Mar 2025

As of 30 Sep 2025, 66 institutional investors reported holding 9,848,942 shares of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT). This represents 19% of the company’s total 52,664,292 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.5% 2,343,561 +14% 0% $7,147,861
CIBC Private Wealth Group LLC 2.8% 1,454,000 +138% 0.01% $4,434,700
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.4% 1,250,025 +3826% 0.01% $3,812,576
HEIGHTS CAPITAL MANAGEMENT, INC 1.7% 883,104 0.86% $2,693,467
HEIGHTS CAPITAL MANAGEMENT, INC 1.7% 883,104 0.86% $2,693,467
GEODE CAPITAL MANAGEMENT, LLC 0.94% 493,386 +25% 0% $1,505,453
BlackRock, Inc. 0.93% 490,189 +53% 0% $1,495,076
DNB ASSET MANAGEMENT AS 0.46% 243,629 +26% 0% $743,068
STATE STREET CORP 0.4% 208,469 +50% 0% $635,830
Informed Momentum Co LLC 0.39% 207,322 0.07% $632,332
UBS Group AG 0.39% 202,845 +388% 0% $618,677
JANE STREET GROUP, LLC 0.37% 193,643 0% $590,612
STIFEL FINANCIAL CORP 0.3% 157,492 +878% 0% $480,373
MILLENNIUM MANAGEMENT LLC 0.16% 84,782 0% $258,585
NORTHERN TRUST CORP 0.15% 80,106 +13% 0% $244,323
TWO SIGMA INVESTMENTS, LP 0.12% 62,401 -9.5% 0% $190,323
LPL Financial LLC 0.09% 49,905 +12% 0% $152,210
Cubist Systematic Strategies, LLC 0.07% 38,985 0% $118,904
Tower Research Capital LLC (TRC) 0.07% 36,116 +2161% 0% $110,154
Hilltop Holdings Inc. 0.07% 35,764 +6.2% 0.01% $109,080
ENVESTNET ASSET MANAGEMENT INC 0.06% 32,264 0% $98,405
Vontobel Holding Ltd. 0.06% 30,862 0% $94,129
TWO SIGMA SECURITIES, LLC 0.06% 30,142 0.01% $91,933
SCOTIA CAPITAL INC. 0.05% 26,476 +16% 0% $80,752
EHP Funds Inc. 0.05% 25,445 0.1% $77,607

Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 21,274 $42,549 -$3 $2.00 3
2025 Q3 9,848,942 $30,049,535 +$16,709,543 $3.05 66
2025 Q2 4,386,909 $11,055,709 +$5,764,677 $2.52 47
2025 Q1 2,156,269 $3,255,605 +$1,699,280 $1.51 41
2024 Q4 1,103,488 $1,235,663 +$63,070 $1.12 34
2024 Q3 1,044,132 $933,420 -$46,041 $0.89 23
2024 Q2 1,085,208 $1,107,053 -$449,318 $1.02 33
2024 Q1 1,447,970 $1,768,115 -$281,766 $1.23 31
2023 Q4 1,519,532 $2,490,748 +$867,449 $1.64 30
2023 Q3 1,000,057 $1,398,056 -$857,178 $1.39 25
2023 Q2 1,236,959 $3,364,899 -$460,248 $2.72 25
2023 Q1 1,415,902 $2,944,553 -$152,124 $2.08 25
2022 Q4 1,488,966 $4,481,066 +$2,064,567 $3.01 21
2022 Q3 803,086 $3,837,000 +$2,761 $4.78 16
2022 Q2 702,489 $3,605,000 -$247,792 $5.13 16
2022 Q1 741,045 $4,646,000 +$150,132 $6.27 18
2021 Q4 812,545 $6,094,000 +$265,795 $7.50 18
2021 Q3 777,709 $5,467,007 +$107,409 $7.03 16
2021 Q2 754,563 $5,992,008 -$382,067 $7.94 21
2021 Q1 794,962 $6,765,734 +$295,356 $8.51 20
2020 Q4 766,370 $5,280,007 -$45,186 $6.89 16
2020 Q3 772,286 $5,931,008 -$23,065 $7.71 16
2020 Q2 682,819 $4,718,007 -$1,382,287 $6.91 13
2020 Q1 701,275 $3,888,006 +$236,511 $5.51 19
2019 Q4 643,351 $6,542,051 +$350,924 $10.16 16
2019 Q3 613,439 $3,251,026 -$112,684 $5.30 18
2019 Q2 635,786 $3,270,026 +$172,218 $5.13 16
2019 Q1 601,769 $4,664,039 +$3,059,819 $7.75 15
2018 Q4 221,530 $380,009 -$32,735 $1.72 13
2018 Q3 122,245 $909,038 +$909,038 $7.55 11